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ABSTRACT
The increase of drug expenditure in the hospital has facilitated the implementation of 
an evidence-based drug formulary. The aim of this study was to assess the change 
in antibacterial use after the implementation of an evidence-based drug formulary in a 
private hospital at Tanjung Enim, Sumatera Selatan, Indonesia. This study used a pre-
posttest design. Drug use data in the period before (2010-2011) and after (2012-2013) 
the formulary implementation were extracted from the hospital medical records. The drug 
use in the hospital before and after the implementation was compared using t-test and 
chi-square test, with the significance level of 0.05. Average number of drugs prescribed 
per prescription after the implementation was similar with that before the implementation 
(4.4 vs 4.6; p > 0.05). However, the proportion of generic drugs prescribed increased 
significantly after the formulary implementation (17.0% vs 52.7%; p < 0.05). Moreover, 
it was still significantly increased when the analysis was conducted only for antibacterial 
drugs (25.9% vs 72.0%; p < 0.05). Average drug cost per prescription was 34% lower 
after the intervention (p < 0.05), and the average cost for antibacterial drug was also 
decreased (26%). The use of antibacterial drugs was significantly decreased after the 
intervention (12.5% vs 6.9%; p < 0.05). The most often antibacterial drugs prescribed 
before the interventions were beta-lactams and macrolides; while quinolones were more 
increasingly used after the intervention. In conclusion, the implementation of evidence-
based hospital drug formulary in a private hospital at Tanjung Enim, Sumatera Selatan 
significantly increase generic drug use and decreased antibacterial use and average drug 
cost per prescription.   
ABSTRAK
Peningkatan belanja obat di rumah sakit menyebabkan dibuatnya formularium obat 
berbasis bukti. Tujuan dari penelitian ini adalah untuk menilai perubahan penggunaan 
antibakteri setelah implementasi formularium obat berbasis bukti di rumah sakit swasta di 
Tanjung Enim, Sumatera Selatan, Indonesia. Penelitian ini menggunakan rancangan pre-
post tes menggunakan data rekam medik rumah sakit dari periode sebelum (2010-2011) 
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dan setelah (2012-2013) implementasi formularium. Indikator penggunaan obat sebelum 
dan sesudah implementasi dibandingkan dengan menggunakan uji t dan chi square, 
dengan tingkat signifikansi 0,05. Jumlah rata-rata obat yang diresepkan perlembar  resep 
sebelum dan setelah implementasi setara  (4,4 vs 4,6; p > 0,05). Namun, proporsi obat 
generik yang diresepkan meningkat secara nyata setelah penerapan formularium (17,0 
vs 52,7%; p <0,05). Selain itu peningkat secara nyata masih dijumpai ketika analisis 
dilakukan hanya untuk antibakteri (25,9 vs 72,0%; p <0,05). Rata-rata biaya obat per 
resep adalah 34% lebih rendah setelah implementasi (p <0,05) dan biaya rata-rata untuk 
antibakteri juga menurun (26%). Penggunaan antibakteri secara nyata menurun setelah 
implementasi (12,5 vs 6,9%; p <0,05).  Antibakteri yang paling sering diresepkan sebelum 
implementasi adalah beta-laktam dan makrolida, sementara kuinolon yang lebih semakin 
digunakan setelah implementasi. Kesimpulan, implementasi formularium obat rumah sakit 
berbasis bukti di rumah sakit swasta Tanjung Enim, Sumatra Selatan meningkatkan secara 
nyata penggunaan obat generik dan menurunkan penggunaan antibakteri serta biaya obat 
rata-rata per resep.
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INTRODUCTION
In developing countries like Indonesia, 
disease patterns have changed from infectious 
diseases to cardiovascular diseases. However, 
infectious diseases are still crucial problems 
in public health. To treat various infectious 
diseases, the total cost to be spent for 
antibacterial drugs is not inexpensive.1,2
In its journey, the use of antibacterial 
drugs tend to be excessive and these drugs 
are generally given to diseases or conditions 
that do not need antibacterial drugs.3,4  Other 
studies also found similar conditions, namely, 
patients who received inadequate antibacterial 
drugs, or those who were given these drugs 
before the results from culture from respiratory 
tract secretions, blood, or pleural fluid were 
obtained, had higher mortality rate compared 
to those who had their pathogenic bacteria 
identified before treatment.5
The forms of irrational antibacterial 
use are quite diverse, from an inappropriate 
choice of antibacterial to various methods of 
administration and duration of use. The habit of 
prescribing antibacterial in inappropriate dose 
(usually under-dose), incorrect frequency, or 
for a too short or too long duration will reduce 
their efficacy and create serious resistance 
problem.6
In order to ensure appropriate and 
rational use of antibacterial, particularly in the 
healthcare institution/hospital environment, 
the principles of antibacterial stewardship 
should be applied consistently. One of the 
principles is the development of evidence-
based formulary. The development of this 
formulary along with continuous education on 
antibacterial use are essential approaches to 
be applied, and medical practitioners should 
follow the us education periodically.7,8 The 
study was performed to  assess the change in 
antibacterial use after the implementation of 
an evidence-based drug formulary in a private 
hospital at Tanjung Enim, Sumatera Selatan, 
Indonesia.
MATERIALS AND METHODS
This study used a pre-posttest design. The 
intervention was the implementation of a new 
drug formulary, emphasizing on evidence-
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based treatment and generic formulation. The 
development of evidence-based formulary 
was conducted after data collection and 
analysis in 2010-2011 at a private hospital at 
Tanjung Enim, Sumatera Selatan, Indonesia. 
Based on data in 2010-2011, the draft of 
evidence-based formulary was prepared. 
Expert review was conducted on the formulary 
draft before the implementation in healthcare. 
This study analyzed more data 2 years after 
the implementation, namely 2012-2013. 
Drug use data in the period before (2010-
2011) and after the formulary implementation 
(2012-2013) were extracted from the hospital 
medical records. The drug use in hospital 
before and after the intervention w compared 
using t-test and chi-square test, with the 
significance level of 0.05. Drug use items 
compared were the average numbers of drugs 
prescribed per prescription, the proportions of 
generic drugs prescribed, average drug costs 
per prescription, and the proportions of drug 
therapeutic classes. Generic drug proportions 
and average drug costs were also compared 
specifically for antibacterial drugs.  
RESULTS
There were 35,032 prescriptions 
before the formulary implementation and 
8,255 prescriptions after the formulary 
implementation. TALE 1 summarizes the 
comparison of the prescriptions before 
and after the evidence-based formulary 
implementation. There was no difference in 
the average number of drugs prescribed per 
prescription before and after the formulary 
implementation (4.4 vs 4.6; p > 0.05). The 
proportion of generic drugs prescribed was 
significantly higher after the formulary 
implementation (17.0 vs 52.7%; p < 0.01). 
The average drug cost per prescription was 
significantly lower after the implementation 
of formulary (before vs after 261.900 vs IDR 
172.600; p < 0.01).  
TABLE 1. Characteristics of prescriptions before and after the formulary implementation
Characteristics Before Implementation
After
Implementation p
Number of drug per 
prescription (mean ± SD) 4.4 ± 1.7 4.6± 2.2 >0.05
Proportion of generic drugs 
prescribed (%) 17.0 52.7 < 0.01
Drug cost per prescription 
(IDR)
Mean ± SD 261.900  ± 258.6 172.600 ± 512.8
<0.01
Median 189.600 80.800
Note: IDR = Indonesian rupiah, SD = standard deviation
TABLE 2 shows the change of prescription 
of systemic antibacterial drug classes before 
and after the formulary implementation. There 
were significant decreases in the proportions 
of tetracyclines (0.5 vs 0.2%), penicillins 
(19.5 vs 9.0%), other beta-lactams (43.0 vs 
30.0%), macrolides and lincosamides (19.9 vs 
17.5%) prescribing after the implementation 
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of evidence-based formulary compared to 
before the implementation. Meanwhile, the 
proportions of amphenicols (0.9 vs 2.6%), 
sulfonamides and trimethoprim (3.4 vs 6.1%), 
aminoglycosides (0.0 vs 1.0%), quinolones 
(12.8 vs 32.1%), and other antibacterial drugs 
(0.0 vs 1.4%) after formulary implementation 
were significantly higher compared to those 
before the implementation.  
TABLE 2.  Changes in the prescribing of systemic antibacterial drug classes before and after the 
evidence-based formulary implementation
Antibacterial drug class
Before 
Implementation (%)
After 
Implementation
(%)
p
Tetracyclines 0.5 0.2 <0.01
Amphenicols 0.9 2.6 <0.01
Beta-lactam antibacterials: penicillins 19.5 9.0 <0.01
Other beta-lactam antibacterial drugs 43.0 30.0 <0.01
Sulfonamides and trimethoprim 3.4 6.1 <0.01
Macrolides, lincosamides 19.9 17.5 <0.01
Aminoglycosides 0.0 1.0 <0.01
Quinolones 12.8 32.1 <0.01
Other antibacterial drugs 0.0 1.4 < 0.01
In TABLE 3, it is shown that the 
prescription of generic antibacterial drugs 
increased significantly after the formulary 
implementation (24.4% vs 72.0%, p < 0.01). 
With the implementation of the formulary, 
the average cost for antibacterial drugs 
decreased significantly from IDR 241.700  per 
prescription to IDR 180.100 (p < 0.01).
TABLE 3.  Characteristics of antibacterial drug prescriptions before and after the formulary implemen-
tation
Characteristics BeforeImplementation
After
Implementation p
Proportion of generic antibacterial  
drugs prescribed (%) 24.4% 72.0% <0.01
Antibacterial drug cost per 
prescription (IDR)
Mean ± SD 241.700 ± 179.7 180.100 ± 401.6 <0.01
Median 197.500 55.600
Note: IDR = Indonesian rupiah, SD = standard deviation
J Med Sci, Volume 49, No. 1, 2017 January: 16-22
20
DISCUSSION
In order to use antibacterial drugs 
appropriately and rationally, particularly in the 
healthcare institution/hospital environment, 
the principle of antibacterial stewardship 
should be applied consistently. Continuous 
education on the use of antibacterial drugs is an 
essential approach that is needed to be applied 
and medical practitioners should follow it 
periodically. The evidence-based treatment 
approach for infectious diseases based on the 
results of current studies is really needed to 
update the knowledge in antibacterial drug 
use.9-12  
Patterson et al. reported that 92% 
antibacterial drug prescribing by general 
practitioners for otitis media was inappropriate, 
and based on microbiological analysis, 
there were no bacteria found. The type of 
antibacterial prescribed was often incorrect 
because the prescribing was generally not 
consistent with the suspected pathogenic 
bacteria.13,14
There are some efforts that can be done 
to control irrational drug use, including 
managerial, operational, and educational 
approaches. The managerial effort includes 
the application of strategy and policy which 
is basically aimed to increase the quality of 
prescribing, namely, rational prescribing. 
Strategy to carry out this effort includes 
increasing the quality of prescribing through 
various educational approach. Health service 
should equip itself with updated information 
and provide guidance to optimize drug use. 
To achieve this, principles of evidence-based 
medicine should be applied correctly.15,16
Inadequate and inappropriate antibacterial 
drug use is often found in daily practice, both 
in primary health service and in hospitals. 
Various studies found that inappropriate 
prescribing of antibacterial lead to the risk 
of unknown adverse effects and bacterial 
resistance in the long run, and these will 
increase the morbidity and mortality. Based 
on the current scientific evidence, there are a 
lot of unnecessary antibacterial drug use.  
Evidence-based medicine formulary is 
developed to provide a guidance for doctors 
and medical practitioners to provide treatment 
optimally based on current scientific evidence 
that is reliable and scientifically accountable. 
Efforts in keeping up-to-date with current 
treatment information should become an 
integral part of public health service.
One of the important steps in the treatment 
process is drug selection. In this step, a medical 
practitioner should determine the type of 
drugs needed by the patients. Prescribed drugs 
should be the most efficacious and safe for the 
patients. Unfortunately, often the decision-
making the process to choose drugs is not 
based on the most recent and valid scientific 
evidence.
One of the interesting phenomena often 
escapes our attention is the variability between 
clinicians in choosing the type of drugs for 
the patients. This variability in choosing 
antibacterial for one indication leads to high 
drug cost and increased risk of bacterial 
resistance in the particular healthcare unit.17,18
In health service such as a hospital, 
this problem can be solved by providing a 
formulary. With this formulary, drugs used 
are those that are really needed, avoiding the 
excessive cost to buy unnecessary drugs. Drug 
selection also means to select only drug-of-
choice, while avoiding to provide unnecessary 
drugs, particularly if they are not supported by 
convincing scientific evidence. With a good 
formulary, a hospital indirectly ensures the 
availability of drugs with the best efficacy and 
safety, while drugs with questionable benefit 
are not provided. This system will increase 
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patient trust to a medical practitioner because 
they understand that the prescribed drugs are 
drugs of choice that have been thoroughly 
studied in terms of efficacy, quality, and 
safety.19,20
Research conducted a study comparing 
drug cost before and after drug formulary 
implementation. In this study, it was found 
that the application of drug formulary reduced 
drug cost more than 50% in a relatively short 
period.21
CONCLUSION
The implementation of evidence-based 
hospital drug formulary in a private hospital at 
Tanjung Enim, Sumatera Selatan significantly 
increases generic drug use and decreases 
antibacterial use and average drug cost per 
prescription. 
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